North America Polymerase Chain Reaction Market Size & Outlook
North America polymerase chain reaction market, 2018-2030 (US$M)
Related Markets
North America polymerase chain reaction market highlights
- The North America polymerase chain reaction market generated a revenue of USD 11,306.2 million in 2023.
- The market is expected to grow at a CAGR of -8.8% from 2024 to 2030.
- In terms of segment, conventional pcr was the largest revenue generating type in 2023.
- Conventional PCR is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2024 to 2030.
North America data book summary
| Market revenue in 2023 | USD 11,306.2 million |
| Market revenue in 2030 | USD 5,946.3 million |
| Growth rate | -8.8% (CAGR from 2023 to 2030) |
| Largest segment | Conventional pcr |
| Fastest growing segment | Conventional PCR |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Conventional PCR |
| Key market players worldwide | Thermo Fisher Scientific Inc, Danaher Corp, Abbott Laboratories, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Qiagen NV, Roche Holding AG ADR, Standard BioTools Inc, Stilla, Microsynth |
Other key industry trends
- In terms of revenue, North America region accounted for 36.4% of the global polymerase chain reaction market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- MEA is the fastest growing regional market and is projected to reach USD 564.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Polymerase Chain Reaction Market Scope
Polymerase Chain Reaction Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America polymerase chain reaction market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to polymerase chain reaction market will help companies and investors design strategic landscapes.
Conventional pcr was the largest segment with a revenue share of 5.04% in 2023. Horizon Databook has segmented the North America polymerase chain reaction market based on conventional pcr covering the revenue growth of each sub-segment from 2018 to 2030.
In 2022, North America dominated the market and held the largest share. Growth can be attributed to the rising prevalence of chronic diseases, genetic disorders, and infectious diseases, as well as increasing demand for rapid diagnostic tests and the growing geriatric population.
Furthermore, significant investments in gene-based research and the presence of leading players, such as Thermo Fisher Scientific Inc.; Bio-Rad Laboratories, Inc.; & Agilent Technologies, have also positively influenced the market.
Another factor driving the growth in the market is several technological advancements, such as microfluidic PCR in droplets, on-chip & off-chip thermocycling, and on-chip integration. For instance, in January 2021, LexaGene launched a microfluidic PCR device as an EUA test.
Reasons to subscribe to North America polymerase chain reaction market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America polymerase chain reaction market databook
-
Our clientele includes a mix of polymerase chain reaction market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America polymerase chain reaction market , including forecasts for subscribers. This continent databook contains high-level insights into North America polymerase chain reaction market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America polymerase chain reaction market size, by country, 2018-2030 (US$M)
North America Polymerase Chain Reaction Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
